Study in Patients With COPD
NCT00215449 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 690
Last updated 2010-11-11
Summary
The purpose of this study is to determine the efficacy and safety of the investigational drug in the treatment of COPD in comparison with a placebo.
Conditions
Interventions
- DRUG
-
Formoterol Fumarate
Sponsors & Collaborators
-
Dey
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Primary Completion
- 2005-12-31
- Completion
- 2006-04-30
Countries
- United States
Study Locations
More Related Trials
-
NVA237 BID Versus Placebo Twelve-week Efficacy Study
NCT01715298 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT01168310 ·Status: COMPLETED ·Phase: PHASE2
-
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
NCT03414541 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT01054885 ·Status: COMPLETED ·Phase: PHASE3
-
Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)
NCT00742248 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease
NCT01113593 ·Status: COMPLETED ·Phase: PHASE2
-
Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol
NCT01555099 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo
NCT01072149 ·Status: COMPLETED ·Phase: PHASE3
-
A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT00685841 ·Status: COMPLETED ·Phase: PHASE3
-
A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT01053988 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
NCT04714294 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00545311 ·Status: COMPLETED ·Phase: PHASE1
-
Simvastatin in Chronic Obstructive Pulmonary Disease (COPD)
NCT00680641 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT01013142 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPD
NCT00749411 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of NVA237 on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01154127 ·Status: COMPLETED ·Phase: PHASE3
-
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
NCT06154837 ·Status: RECRUITING ·Phase: PHASE1
-
A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease
NCT01009424 ·Status: WITHDRAWN ·Phase: PHASE1
-
CHF5993 and CHF1535 pMDI on Lung Hyperinflation and Exercise Endurance Time in Subjects With COPD
NCT05097014 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease
NCT01033487 ·Status: COMPLETED ·Phase: PHASE2
-
IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study
NCT00883584 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease
NCT00219622 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate)
NCT01488019 ·Status: COMPLETED ·Phase: PHASE4
-
NVA237 Versus Placebo 12-week Efficacy Study
NCT01709864 ·Status: COMPLETED ·Phase: PHASE3
-
Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD
NCT00064402 ·Status: COMPLETED ·Phase: PHASE3